AAAAAA

   
Results: 1-9 |
Results: 9
FORMULATION OF A HEPATITIS-C VIRUS-RNA PANEL FOR STANDARDIZATION OF NUCLEIC-ACID TESTING OF BLOOD, PLASMA, AND THEIR DERIVED PRODUCTS
Authors: YU MW FARSHID M MASON BL TAN D KOCH WH YUWEN H HSIA CC TABOR E
Citation: Mw. Yu et al., FORMULATION OF A HEPATITIS-C VIRUS-RNA PANEL FOR STANDARDIZATION OF NUCLEIC-ACID TESTING OF BLOOD, PLASMA, AND THEIR DERIVED PRODUCTS, Hepatology, 28(4), 1998, pp. 1614-1614
OVEREXPRESSION OF TOPOISOMERASE-II AND P53 IN HEPATOCELLULAR-CARCINOMA
Authors: NAKASHIMA Y YUWEN H HSIA CC NAKASHIMA O KOJIRO M TABOR E
Citation: Y. Nakashima et al., OVEREXPRESSION OF TOPOISOMERASE-II AND P53 IN HEPATOCELLULAR-CARCINOMA, Hepatology, 24(4), 1996, pp. 1701-1701
OVEREXPRESSION OF TOPOISOMERASE-II IN HUMAN HEPATOCELLULAR CARCINOMASAND BINDING OF WILD-TYPE P53 BY TOPOISOMERASE-II
Authors: YUWEN H HSIA CC NAKASHIMA Y EVANGELISTA A TABOR E
Citation: H. Yuwen et al., OVEREXPRESSION OF TOPOISOMERASE-II IN HUMAN HEPATOCELLULAR CARCINOMASAND BINDING OF WILD-TYPE P53 BY TOPOISOMERASE-II, Hepatology, 24(4), 1996, pp. 1897-1897
GENOMIC VARIATIONS IN THE HEPATITIS-B VIRUS X GENE IN HEPATOCELLULAR-CARCINOMA
Authors: HSIA CC YUWEN H TABOR E
Citation: Cc. Hsia et al., GENOMIC VARIATIONS IN THE HEPATITIS-B VIRUS X GENE IN HEPATOCELLULAR-CARCINOMA, Hepatology, 22(4), 1995, pp. 345-345
IDENTIFICATION OF 2 P53 BINDING-PROTEINS USING A RECOMBINANT VACCINIAVIRUS CONTAINING THE WILD-TYPE HUMAN P53 GENE
Authors: YUWEN H KAZACHKOV Y MORIMITSU Y TABOR E
Citation: H. Yuwen et al., IDENTIFICATION OF 2 P53 BINDING-PROTEINS USING A RECOMBINANT VACCINIAVIRUS CONTAINING THE WILD-TYPE HUMAN P53 GENE, Biochemical and biophysical research communications, 213(3), 1995, pp. 986-993
ASSOCIATION BETWEEN HEPATITIS-C VIRUS (HCV) INFECTION AND LIVER-CANCER MORTALITY WITHIN A JAPANESE POPULATION ENDEMIC FOR HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) INFECTION
Authors: STUVER S YUWEN H OKAYAMA A TACHIBANA N TSUBOUCHI H MUELLER N TABOR E
Citation: S. Stuver et al., ASSOCIATION BETWEEN HEPATITIS-C VIRUS (HCV) INFECTION AND LIVER-CANCER MORTALITY WITHIN A JAPANESE POPULATION ENDEMIC FOR HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) INFECTION, Hepatology, 20(4), 1994, pp. 10000285-10000285
WILD-TYPE-P53 PRODUCED BY RECOMBINANT VACCINIA VIRUS FOR THE STUDY OFITS FUNCTION IN HEPATOCELLULAR-CARCINOMA CELL-LINES
Authors: YUWEN H KAZACHKOV Y MORIMITSU Y TABOR E
Citation: H. Yuwen et al., WILD-TYPE-P53 PRODUCED BY RECOMBINANT VACCINIA VIRUS FOR THE STUDY OFITS FUNCTION IN HEPATOCELLULAR-CARCINOMA CELL-LINES, Hepatology, 20(4), 1994, pp. 10000286-10000286
HEPATOCELLULAR-CARCINOMA - LACK OF ASSOCIATION WITH A UNIQUE HEPATITIS-C VIRUS NUCLEOTIDE-SEQUENCE
Authors: YUWEN H BAYLEY AC CAIRNS J TABOR E
Citation: H. Yuwen et al., HEPATOCELLULAR-CARCINOMA - LACK OF ASSOCIATION WITH A UNIQUE HEPATITIS-C VIRUS NUCLEOTIDE-SEQUENCE, The Journal of infectious diseases, 169(3), 1994, pp. 706-707
SEQUENCE VARIATION OF THE HEPATITIS-C VIRUS (HCV) 5'-NONCODING REGIONIN THE SERA OF HEPATOCELLULAR-CARCINOMA (HCC) PATIENTS
Authors: YUWEN H BAYLEY AC CAIRNS J TABOR E
Citation: H. Yuwen et al., SEQUENCE VARIATION OF THE HEPATITIS-C VIRUS (HCV) 5'-NONCODING REGIONIN THE SERA OF HEPATOCELLULAR-CARCINOMA (HCC) PATIENTS, Hepatology, 18(4), 1993, pp. 10000079-10000079
Risultati: 1-9 |